QA: Propanc Biopharma Inc. in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001517681_2021_Propanc_Biopharma_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001517681')"}

Graph

Absolute values for 0001517681, Propanc Biopharma Inc.

  xvar xval
0 AssetsCurrent 69,022
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 5,747
3 remainder_Assets 23,749
4 LiabilitiesCurrent 3,739,943
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,281,464
9 ResearchAndDevelopmentExpense 179,987
10 remainder_Expenses -101,919
11 remainder_Revenues 0
12 remainder_NetIncome -1,381,191
13 remainder_ComprehensiveNetIncome 200,673
  yvar yval
0 Assets 98,518
1 Liabilities 3,739,943
2 Expenses 3,359,532
3 Revenues 0
4 StockholdersEquity -3,641,425
5 NetIncome -4,740,723
6 ComprehensiveNetIncome -4,640,386
7 BaseVar 4,389,928
8 EconomicCapitalRatio -5.68

Edgar->Model Mapping

Feature Distribution

Change over Time